Previous studies reported that IGFBP5 modulated pancreatic cancer cell growth and survival through the MAPK or PI3K pathway, and promoted prostate cancer growth via activating the PI3K pathway 16, 17. The gene discussed is IGFBP5; the disease is prostate carcinoma.